Koyfin Home > Directory > Health Care > Amphastar Pharma > EBITDA / Interest Expenses

Amphastar Pharma EBITDA / Interest Expenses Chart (AMPH)

Amphastar Pharma annual/quarterly EBITDA / Interest Expenses from 2014 to 2018. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Amphastar Pharma EBITDA / Interest Expenses for the quarter ending September 09, 2018 was $54m a 91.52% increase of 49m year over year
  • Amphastar Pharma EBITDA / Interest Expenses for the last 12 months ending September 09, 2018 was $6m a -96.14% decrease of -6m year over year
  • Amphastar Pharma Annual EBITDA / Interest Expenses for 2017 was $14m a -107.84% decrease of -16m from 2016
  • Amphastar Pharma Annual EBITDA / Interest Expenses for 2016 was $30m a 67.33% increase of 20m from 2015
  • Amphastar Pharma Annual EBITDA / Interest Expenses for 2015 was $10m a -227.57% decrease of -22m from 2014
Other Ratios Metrics:
  • Amphastar Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $12m a -1.34% decrease of 0m year over year
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
  • Amphastar Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $14m a -1.53% decrease of 0m year over year
View Chart On Koyfin

Quarterly AMPH EBITDA / Interest Expenses Data

09/2018$54m
06/2018$12m
12/2017$17m
09/2017$5m
06/2017$25m
03/2017$14m
09/2016$34m
06/2016$46m
03/2016$21m
12/2015$86m

Annual AMPH EBITDA / Interest Expenses Data

2017$14m
2016$30m
2015$10m
2013$32m